Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@ipharmacenter Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::982887414841556997.png) @ipharmacenter ipharmacenter

ipharmacenter posts on X about $4503t, novartis, eli lilly, drugs the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::982887414841556997/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::982887414841556997/c:line/m:interactions.svg)

- X Week XXXXX +903%
- X Month XXXXX +14,356%
- X Months XXXXX -XX%
- X Year XXXXX +18%

### Mentions: X [#](/creator/twitter::982887414841556997/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::982887414841556997/c:line/m:posts_active.svg)

- X Week XX +367%
- X Month XX +600%
- X Months XX -XX%
- X Year XX -XX%

### Followers: XXX [#](/creator/twitter::982887414841556997/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::982887414841556997/c:line/m:followers.svg)

- X Week XXX +0.78%
- X Month XXX +0.78%
- X Months XXX -XXXX%
- X Year XXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::982887414841556997/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::982887414841556997/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::982887414841556997/influence)
---

**Social category influence**
[stocks](/list/stocks)  XX%

**Social topic influence**
[$4503t](/topic/$4503t) #5, [novartis](/topic/novartis) 14.29%, [eli lilly](/topic/eli-lilly) 7.14%, [drugs](/topic/drugs) XXXX%

**Top assets mentioned**
[Novartis AG (NVS)](/topic/novartis) [Eli Lilly and Company (LLY)](/topic/eli-lilly)
### Top Social Posts [#](/creator/twitter::982887414841556997/posts)
---
Top posts by engagements in the last XX hours

"#AstraZeneca presenting multiple trial outcomes at #ESMO25 Fill the latest updates on @ipharmacenter #ESMO2025 updates here:"  
[X Link](https://x.com/ipharmacenter/status/1979773804160364847) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-19T04:57Z XXX followers, XXX engagements


"#Xtandi Plus #Leuprolide Cuts Risk of Death by XX% in Advanced #ProstateCancer Delivering 8-Year Survival Benefit #ESMO25 #ESMO2025 #Pfizer #pharma #pharmaceutical #ESMOAmbassadors #Astellas"  
[X Link](https://x.com/ipharmacenter/status/1980534244800856314) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:18Z XXX followers, XX engagements


"Find all #ESMO25 updates of major #pharmaceutical companies at one place on @ipharmacenter #ESMO2025 #ESMOAmbassadors #immunotherapy #pfizer #novartis #astrazeneca #johnsonandjohnson #astellas #merck #BMS"  
[X Link](https://x.com/ipharmacenter/status/1980540251014857177) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:42Z XXX followers, XXX engagements


"Eli Lilly's orforglipron shines in Phase X trials for Type X Diabetes Great potential for a new oral treatment option. Read more about these promising results: #pharma #pharmaceutical #breakingnews #weightloss #revenues #Type2Diabetes #EliLilly"  
[X Link](https://x.com/ipharmacenter/status/1978705210009965010) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-16T06:10Z XXX followers, XX engagements


"Several companies have provided updates for drugs that are in development for #bladdercancer at #ESMO25 #Roche presented data of #Tecentriq #Pfizer & #Merck presented the perioperative data of #Keytruda + #Padcev combination Find details here #ESMo2025"  
[X Link](https://x.com/ipharmacenter/status/1980674362329252263) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:35Z XXX followers, XX engagements


"#Breastcancer updates at #ESMO2025 #AstraZenecas #Datroway showed survival benefit in TNBC #Enhertu showed benefits in eBC #Novartis #Kisqali showed disease recurrence in eBC #lillys #Verzenio showed long-term survival benefit #ESMO25 #OncoAlert"  
[X Link](https://x.com/ipharmacenter/status/1980675281460556163) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:39Z XXX followers, XX engagements


"#Merck's #Keytruda shows meaningful survival benefits for an #immunotherapy-based approach in this challenging #ovariancancer population #ESMO2025 #ESMO25 #OncoAlerts #OncoAlert #Pharma #pharmaceutical #healthcare"  
[X Link](https://x.com/ipharmacenter/status/1980695566947373389) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T17:59Z XXX followers, XX engagements


"AstraZeneca presented data Tecentriq with ctDNA testing. If approved it could mark a new era of precision medicine in bladder cancer management #ESMO25 #ESMO2025 #OncoAlert #Oncoalerts #ESMODailyReporter #cancer #pharma #pharmaceutical"  
[X Link](https://x.com/ipharmacenter/status/1980696260467388675) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T18:02Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@ipharmacenter Avatar @ipharmacenter ipharmacenter

ipharmacenter posts on X about $4503t, novartis, eli lilly, drugs the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX +903%
  • X Month XXXXX +14,356%
  • X Months XXXXX -XX%
  • X Year XXXXX +18%

Mentions: X #

Mentions Line Chart

  • X Week XX +367%
  • X Month XX +600%
  • X Months XX -XX%
  • X Year XX -XX%

Followers: XXX #

Followers Line Chart

  • X Week XXX +0.78%
  • X Month XXX +0.78%
  • X Months XXX -XXXX%
  • X Year XXX -XXXX%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XX%

Social topic influence $4503t #5, novartis 14.29%, eli lilly 7.14%, drugs XXXX%

Top assets mentioned Novartis AG (NVS) Eli Lilly and Company (LLY)

Top Social Posts #


Top posts by engagements in the last XX hours

"#AstraZeneca presenting multiple trial outcomes at #ESMO25 Fill the latest updates on @ipharmacenter #ESMO2025 updates here:"
X Link @ipharmacenter 2025-10-19T04:57Z XXX followers, XXX engagements

"#Xtandi Plus #Leuprolide Cuts Risk of Death by XX% in Advanced #ProstateCancer Delivering 8-Year Survival Benefit #ESMO25 #ESMO2025 #Pfizer #pharma #pharmaceutical #ESMOAmbassadors #Astellas"
X Link @ipharmacenter 2025-10-21T07:18Z XXX followers, XX engagements

"Find all #ESMO25 updates of major #pharmaceutical companies at one place on @ipharmacenter #ESMO2025 #ESMOAmbassadors #immunotherapy #pfizer #novartis #astrazeneca #johnsonandjohnson #astellas #merck #BMS"
X Link @ipharmacenter 2025-10-21T07:42Z XXX followers, XXX engagements

"Eli Lilly's orforglipron shines in Phase X trials for Type X Diabetes Great potential for a new oral treatment option. Read more about these promising results: #pharma #pharmaceutical #breakingnews #weightloss #revenues #Type2Diabetes #EliLilly"
X Link @ipharmacenter 2025-10-16T06:10Z XXX followers, XX engagements

"Several companies have provided updates for drugs that are in development for #bladdercancer at #ESMO25 #Roche presented data of #Tecentriq #Pfizer & #Merck presented the perioperative data of #Keytruda + #Padcev combination Find details here #ESMo2025"
X Link @ipharmacenter 2025-10-21T16:35Z XXX followers, XX engagements

"#Breastcancer updates at #ESMO2025 #AstraZenecas #Datroway showed survival benefit in TNBC #Enhertu showed benefits in eBC #Novartis #Kisqali showed disease recurrence in eBC #lillys #Verzenio showed long-term survival benefit #ESMO25 #OncoAlert"
X Link @ipharmacenter 2025-10-21T16:39Z XXX followers, XX engagements

"#Merck's #Keytruda shows meaningful survival benefits for an #immunotherapy-based approach in this challenging #ovariancancer population #ESMO2025 #ESMO25 #OncoAlerts #OncoAlert #Pharma #pharmaceutical #healthcare"
X Link @ipharmacenter 2025-10-21T17:59Z XXX followers, XX engagements

"AstraZeneca presented data Tecentriq with ctDNA testing. If approved it could mark a new era of precision medicine in bladder cancer management #ESMO25 #ESMO2025 #OncoAlert #Oncoalerts #ESMODailyReporter #cancer #pharma #pharmaceutical"
X Link @ipharmacenter 2025-10-21T18:02Z XXX followers, XXX engagements

creator/x::ipharmacenter
/creator/x::ipharmacenter